nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—Balance disorder—Varenicline—nicotine dependence	0.0306	0.0615	CcSEcCtD
Ezogabine—Nystagmus—Varenicline—nicotine dependence	0.0234	0.0471	CcSEcCtD
Ezogabine—KCNQ3—cardiovascular system—nicotine dependence	0.0226	0.194	CbGeAlD
Ezogabine—KCNQ5—midbrain—nicotine dependence	0.022	0.189	CbGeAlD
Ezogabine—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0218	0.0565	CbGpPWpGaD
Ezogabine—Nephrolithiasis—Varenicline—nicotine dependence	0.0208	0.0418	CcSEcCtD
Ezogabine—Disturbance in attention—Varenicline—nicotine dependence	0.0193	0.0388	CcSEcCtD
Ezogabine—Dysarthria—Varenicline—nicotine dependence	0.0177	0.0355	CcSEcCtD
Ezogabine—KCNQ3—midbrain—nicotine dependence	0.0177	0.151	CbGeAlD
Ezogabine—Coordination abnormal—Varenicline—nicotine dependence	0.017	0.0342	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—CHRNB3—nicotine dependence	0.0155	0.0403	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNB3—nicotine dependence	0.0155	0.0403	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNA6—nicotine dependence	0.0147	0.0382	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—CHRNA6—nicotine dependence	0.0147	0.0382	CbGpPWpGaD
Ezogabine—Euphoric mood—Varenicline—nicotine dependence	0.0144	0.0289	CcSEcCtD
Ezogabine—KCNQ4—brain—nicotine dependence	0.0142	0.122	CbGeAlD
Ezogabine—KCNQ5—brain—nicotine dependence	0.0138	0.118	CbGeAlD
Ezogabine—Disorientation—Varenicline—nicotine dependence	0.0136	0.0273	CcSEcCtD
Ezogabine—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.0135	0.035	CbGpPWpGaD
Ezogabine—Amnesia—Varenicline—nicotine dependence	0.0129	0.026	CcSEcCtD
Ezogabine—Increased appetite—Varenicline—nicotine dependence	0.0129	0.026	CcSEcCtD
Ezogabine—Osteoarthritis—Varenicline—nicotine dependence	0.0122	0.0244	CcSEcCtD
Ezogabine—Psychotic disorder—Varenicline—nicotine dependence	0.0119	0.0238	CcSEcCtD
Ezogabine—Urinary retention—Varenicline—nicotine dependence	0.0116	0.0232	CcSEcCtD
Ezogabine—Liver function test abnormal—Varenicline—nicotine dependence	0.0112	0.0225	CcSEcCtD
Ezogabine—KCNQ3—brain—nicotine dependence	0.0111	0.0951	CbGeAlD
Ezogabine—KCNQ4—Neuronal System—GABRA4—nicotine dependence	0.0106	0.0276	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—GABRA4—nicotine dependence	0.0106	0.0276	CbGpPWpGaD
Ezogabine—Dysphagia—Varenicline—nicotine dependence	0.0105	0.0211	CcSEcCtD
Ezogabine—KCNQ2—brain—nicotine dependence	0.0102	0.0875	CbGeAlD
Ezogabine—KCNQ4—Neuronal System—CHRNB4—nicotine dependence	0.0102	0.0265	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNB4—nicotine dependence	0.0102	0.0265	CbGpPWpGaD
Ezogabine—Weight increased—Varenicline—nicotine dependence	0.00956	0.0192	CcSEcCtD
Ezogabine—NAT2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00954	0.0248	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—CHRNA5—nicotine dependence	0.00948	0.0246	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNA5—nicotine dependence	0.00948	0.0246	CbGpPWpGaD
Ezogabine—Infestation—Varenicline—nicotine dependence	0.00937	0.0188	CcSEcCtD
Ezogabine—Infestation NOS—Varenicline—nicotine dependence	0.00937	0.0188	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP2A7—nicotine dependence	0.009	0.0234	CbGpPWpGaD
Ezogabine—NAT2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00887	0.023	CbGpPWpGaD
Ezogabine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00886	0.0178	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—CHRNB3—nicotine dependence	0.00838	0.0218	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CHRNB3—nicotine dependence	0.00838	0.0218	CbGpPWpGaD
Ezogabine—Hallucination—Varenicline—nicotine dependence	0.00837	0.0168	CcSEcCtD
Ezogabine—Urinary tract disorder—Varenicline—nicotine dependence	0.0083	0.0167	CcSEcCtD
Ezogabine—Oedema peripheral—Varenicline—nicotine dependence	0.00828	0.0166	CcSEcCtD
Ezogabine—Urethral disorder—Varenicline—nicotine dependence	0.00824	0.0166	CcSEcCtD
Ezogabine—Visual impairment—Varenicline—nicotine dependence	0.0081	0.0163	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—CHRNA6—nicotine dependence	0.00795	0.0206	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—CHRNA6—nicotine dependence	0.00795	0.0206	CbGpPWpGaD
Ezogabine—Eye disorder—Varenicline—nicotine dependence	0.00786	0.0158	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—CHRNA3—nicotine dependence	0.00773	0.0201	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNA3—nicotine dependence	0.00773	0.0201	CbGpPWpGaD
Ezogabine—Mental disorder—Varenicline—nicotine dependence	0.00737	0.0148	CcSEcCtD
Ezogabine—Malnutrition—Varenicline—nicotine dependence	0.00732	0.0147	CcSEcCtD
Ezogabine—Muscle spasms—Varenicline—nicotine dependence	0.00704	0.0141	CcSEcCtD
Ezogabine—Vision blurred—Varenicline—nicotine dependence	0.0069	0.0139	CcSEcCtD
Ezogabine—Tremor—Varenicline—nicotine dependence	0.00686	0.0138	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—CHRNB2—nicotine dependence	0.00681	0.0177	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNB2—nicotine dependence	0.00681	0.0177	CbGpPWpGaD
Ezogabine—Ill-defined disorder—Varenicline—nicotine dependence	0.00679	0.0136	CcSEcCtD
Ezogabine—Malaise—Varenicline—nicotine dependence	0.0066	0.0133	CcSEcCtD
Ezogabine—Vertigo—Varenicline—nicotine dependence	0.00658	0.0132	CcSEcCtD
Ezogabine—Syncope—Varenicline—nicotine dependence	0.00656	0.0132	CcSEcCtD
Ezogabine—Loss of consciousness—Varenicline—nicotine dependence	0.00643	0.0129	CcSEcCtD
Ezogabine—Anxiety—Varenicline—nicotine dependence	0.00621	0.0125	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—CHRNA4—nicotine dependence	0.00618	0.016	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—CHRNA4—nicotine dependence	0.00618	0.016	CbGpPWpGaD
Ezogabine—Discomfort—Varenicline—nicotine dependence	0.00616	0.0124	CcSEcCtD
Ezogabine—Dry mouth—Varenicline—nicotine dependence	0.00609	0.0122	CcSEcCtD
Ezogabine—Infection—Varenicline—nicotine dependence	0.00593	0.0119	CcSEcCtD
Ezogabine—Shock—Varenicline—nicotine dependence	0.00588	0.0118	CcSEcCtD
Ezogabine—Nervous system disorder—Varenicline—nicotine dependence	0.00586	0.0118	CcSEcCtD
Ezogabine—Thrombocytopenia—Varenicline—nicotine dependence	0.00585	0.0117	CcSEcCtD
Ezogabine—UGT1A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00578	0.015	CbGpPWpGaD
Ezogabine—Hyperhidrosis—Varenicline—nicotine dependence	0.00577	0.0116	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—GABRA4—nicotine dependence	0.00574	0.0149	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—GABRA4—nicotine dependence	0.00574	0.0149	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0056	0.0145	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00553	0.0144	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—CHRNB4—nicotine dependence	0.00551	0.0143	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CHRNB4—nicotine dependence	0.00551	0.0143	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—CYP2A7—nicotine dependence	0.00545	0.0141	CbGpPWpGaD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00538	0.014	CbGpPWpGaD
Ezogabine—Dyspnoea—Varenicline—nicotine dependence	0.00533	0.0107	CcSEcCtD
Ezogabine—Somnolence—Varenicline—nicotine dependence	0.00531	0.0107	CcSEcCtD
Ezogabine—Dyspepsia—Varenicline—nicotine dependence	0.00526	0.0106	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00516	0.0104	CcSEcCtD
Ezogabine—Fatigue—Varenicline—nicotine dependence	0.00515	0.0103	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—CHRNA5—nicotine dependence	0.00512	0.0133	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CHRNA5—nicotine dependence	0.00512	0.0133	CbGpPWpGaD
Ezogabine—Constipation—Varenicline—nicotine dependence	0.00511	0.0103	CcSEcCtD
Ezogabine—CYP2A6—brain—nicotine dependence	0.00508	0.0435	CbGeAlD
Ezogabine—Feeling abnormal—Varenicline—nicotine dependence	0.00492	0.00988	CcSEcCtD
Ezogabine—UGT1A3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00481	0.0125	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00454	0.0118	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP2A7—nicotine dependence	0.00453	0.0118	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00447	0.0116	CbGpPWpGaD
Ezogabine—Asthenia—Varenicline—nicotine dependence	0.00429	0.00861	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—CHRNA3—nicotine dependence	0.00417	0.0108	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CHRNA3—nicotine dependence	0.00417	0.0108	CbGpPWpGaD
Ezogabine—Dizziness—Varenicline—nicotine dependence	0.00395	0.00793	CcSEcCtD
Ezogabine—Rash—Varenicline—nicotine dependence	0.00377	0.00756	CcSEcCtD
Ezogabine—Dermatitis—Varenicline—nicotine dependence	0.00376	0.00756	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—CHRNB2—nicotine dependence	0.00367	0.00954	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CHRNB2—nicotine dependence	0.00367	0.00954	CbGpPWpGaD
Ezogabine—Nausea—Varenicline—nicotine dependence	0.00355	0.00713	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—CHRNA4—nicotine dependence	0.00334	0.00866	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—CHRNA4—nicotine dependence	0.00334	0.00866	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00332	0.00862	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00332	0.00862	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00313	0.00813	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00313	0.00813	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00309	0.00801	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00309	0.00801	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00241	0.00626	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP2A7—nicotine dependence	0.00154	0.00399	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2A7—nicotine dependence	0.000932	0.00242	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.000775	0.00201	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000535	0.00139	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000535	0.00139	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000413	0.00107	CbGpPWpGaD
